TYSON TIMOTHY purchased 211.6% of their position (16.93K shares) of SYROS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $106.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/3/2022ACC: 0001209191-22-051854
+16.93K
Net shares
Net buyer
$106.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
16.93K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.93K
Price / share
$5.72
Trade value
$16.77K
% of position
36.6%
9/29/2022
8K→10.93K
Common Stock
Direct
Shares
+14K
Price / share
$6.37
Trade value
$89.19K
% of position
128.1%
9/30/2022
10.93K→24.93K
Total
Net shares
+16.93K
Net value
$105.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/29/2022 | P · Purchase | +2.93K | $5.72 | $16.77K | 36.6% | 8K | 10.93K |
| Common Stock Direct | 9/30/2022 | P · Purchase | +14K | $6.37 | $89.19K | 128.1% | 10.93K | 24.93K |
| Total | +16.93K | $105.96K | ||||||
Derivative Transactions0
No derivative transactions reported